Shire Plc (SHP)

Sector: Pharma and Biotech     Index: FTSE 100
-3.11%
-119.50p
3,719.50p
17:30 18/10/17
3,719.50p
17:30 18/10/17
DAILY VARIATION
-3.11%
-119.50p
VOLUME
3,739,924
No results
REAL TIME BATS
3,718.50p
08:13 19/10/17
0.07%
2.50p
DATA
52 Week High
5,143.00p
52 Week Low
3,613.00p
Shares Issued
908.51m
Market Cap
£33,792.02m
RiskGrade
118
Beta
1.15
MENU

Shire Plc Overview

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.

slide to see more

Key Personnel

slide to see more
CEO: Flemming Ornskov
CFO: Jeff Poulton
Chairman: Susan Kilsby
Non-Executive Director: David Ginsburg, Sara Mathew, Anne Minto, Dominic Blakemore , Gail D. Fosler , Albert P.L. Stroucken , Ian Clark, Steven Gillis
Senior Independent Director: William Burns
Deputy Company Secretary: Stephen Williams
Non-Executive Director and Company Secretary: Olivier Bohuon

Contact Details

slide to see more
Address: 22 Grenville Street, St Helier, Jersey
Phone: +44 (0) 1256 894 000
Fax: +44 (0) 1256 894 708
Website: http://www.shire.com
Email:

Listings